NCT03855592 Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
| NCT ID | NCT03855592 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fundación Sociedad Española de Oncologia Médica |
| Condition | Thromboembolism |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2018-07-04 |
| Primary Completion | 2026-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2018-07-04 with a primary completion date of 2026-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Epidemiological, observational, non-interventional, multicentric study on patients diagnosed with cancer who develop a venous or arterial thromboembolic episode, symptomatic or incidental, within a month prior to cancer diagnosis or at anytime after such diagnosis
Eligibility Criteria
Inclusion Criteria: * Over 18 years of age with a histologically confirmed diagnosis of malignant tumor. * Venous or arterial thromboembolism episode, symptomatic or incidental, in the month prior or any time after the cancer diagnosis and in the three previous months to enrollment, confirmed with an imaging technique: Doppler echocardiography, computed tomography (CT) angiography, etc. * Signing of informed consent. Exclusion Criteria: * Clinical diagnosis of thromboembolic event without radiological confirmation. * Presenting a single episode of superficial thrombophlebitis without association with another thromboembolic event. * Each patient will be recorded just once, and therefore a second thromboembolic event will be considered a rethrombosis and will be recorded as such. Patients with a rethrombosis and a previous thromboembolic event before the start of the study in each center will not be able to be included.
Contact & Investigator
Andres Muñoz, M.D.
STUDY CHAIR
Hospital General Universitario Gregorio Marañón, Madrid
Frequently Asked Questions
Who can join the NCT03855592 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Thromboembolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03855592 currently recruiting?
Yes, NCT03855592 is actively recruiting participants. Contact the research team at investigacion@mfar.net for enrollment information.
Where is the NCT03855592 trial being conducted?
This trial is being conducted at Alcoy, Spain, Elche, Spain, Palma, Spain, L'Hospitalet de Llobregat, Spain and 11 additional locations.
Who is sponsoring the NCT03855592 clinical trial?
NCT03855592 is sponsored by Fundación Sociedad Española de Oncologia Médica. The principal investigator is Andres Muñoz, M.D. at Hospital General Universitario Gregorio Marañón, Madrid. The trial plans to enroll 700 participants.